SAGE Sage Therapeutics | $13.69 +0.8% | 4/26/2024 | Target Lowered by | HC Wainwright | - | Neutral -> Neutral | $28.00 -> $25.00 | Low | View details for HC Wainwright rating of Sage Therapeutics (NASDAQ:SAGE) on 4/26/2024 |
APLS Apellis Pharmaceuticals | $49.86 +4.0% | 4/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $92.00 | Low | View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 4/26/2024 |
PPBT Purple Biotech | $0.49 -5.8% | 4/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Purple Biotech (NASDAQ:PPBT) on 4/26/2024 |
HOOK Hookipa Pharma | $0.89 +11.2% | 4/26/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $6.50 -> $5.00 | Low | View details for HC Wainwright rating of Hookipa Pharma (NASDAQ:HOOK) on 4/26/2024 |
BPMC Blueprint Medicines | $93.00 +2.5% | 4/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $125.00 | Low | View details for HC Wainwright rating of Blueprint Medicines (NASDAQ:BPMC) on 4/26/2024 |
PRAX Praxis Precision Medicines | $54.80 +3.6% | 4/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $105.00 | Low | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 4/26/2024 |
|
SNDX Syndax Pharmaceuticals | $21.06 +2.4% | 4/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $41.00 | Low | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 4/26/2024 |
ARBK Argo Blockchain | $1.52
| 4/26/2024 | Downgraded by | HC Wainwright | - | Buy -> Neutral | | Low | View details for HC Wainwright rating of Argo Blockchain (NASDAQ:ARBK) on 4/26/2024 |
LSTA Lisata Therapeutics | $2.65 -0.4% | 4/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Lisata Therapeutics (NASDAQ:LSTA) on 4/25/2024 |
MAG MAG Silver | $12.97
| 4/25/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $16.00 -> $17.00 | N/A | View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 4/25/2024 |
URG Ur-Energy | $1.69 +3.7% | 4/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $3.60 -> $3.40 | N/A | View details for HC Wainwright rating of Ur-Energy (NYSEAMERICAN:URG) on 4/25/2024 |
LTRN Lantern Pharma | $5.50 +0.7% | 4/25/2024 | Reiterated by | HC Wainwright | - | Neutral | | Low | View details for HC Wainwright rating of Lantern Pharma (NASDAQ:LTRN) on 4/25/2024 |
GANX Gain Therapeutics | $3.03 -1.3% | 4/25/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 4/25/2024 |
EVO Evotec | $5.02 -1.6% | 4/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $14.00 -> $11.00 | Low | View details for HC Wainwright rating of Evotec (NASDAQ:EVO) on 4/25/2024 |
VKTX Viking Therapeutics | $74.31 +7.9% | 4/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 | Low | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 4/25/2024 |
XOMA XOMA | $25.41 +0.2% | 4/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $74.00 | Low | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 4/25/2024 |
CAPR Capricor Therapeutics | $5.41 +5.0% | 4/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 | Low | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 4/25/2024 |
ACRV Acrivon Therapeutics | $8.46 -0.1% | 4/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Acrivon Therapeutics (NASDAQ:ACRV) on 4/25/2024 |
BIIB Biogen | $208.90 +3.2% | 4/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $325.00 -> $300.00 | Low | View details for HC Wainwright rating of Biogen (NASDAQ:BIIB) on 4/25/2024 |
TVTX Travere Therapeutics | $5.26 -2.4% | 4/24/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $17.00 -> $19.00 | Low | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 4/24/2024 |
NBIX Neurocrine Biosciences | $135.99 -1.3% | 4/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $150.00 | Low | View details for HC Wainwright rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/24/2024 |
DAWN Day One Biopharmaceuticals | $14.92 +12.9% | 4/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 4/24/2024 |
CLIR ClearSign Technologies | $0.75 -7.4% | 4/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of ClearSign Technologies (NASDAQ:CLIR) on 4/24/2024 |
AEYE AudioEye | $14.29 -3.8% | 4/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 | Low | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 4/24/2024 |
OCS Oculis | $12.02 +0.6% | 4/24/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $29.00 -> $28.00 | Low | View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 4/24/2024 |
CORT Corcept Therapeutics | $22.80 +2.7% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $38.00 | Low | View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 4/23/2024 |
GROY Gold Royalty | $2.16 +2.9% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.75 | N/A | View details for HC Wainwright rating of Gold Royalty (NYSEAMERICAN:GROY) on 4/23/2024 |
LEGN Legend Biotech | $45.30 +2.0% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 4/23/2024 |
ATXS Astria Therapeutics | $9.00 -1.9% | 4/23/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $18.00 -> $16.00 | Low | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 4/23/2024 |
MLTX MoonLake Immunotherapeutics | $42.49 +0.6% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $100.00 | Low | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 4/23/2024 |
BTAI BioXcel Therapeutics | $2.63 +0.8% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of BioXcel Therapeutics (NASDAQ:BTAI) on 4/23/2024 |
ENLV Enlivex Therapeutics | $1.44 -0.7% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Enlivex Therapeutics (NASDAQ:ENLV) on 4/23/2024 |
RNAC Cartesian Therapeutics | $21.03 +0.6% | 4/23/2024 | Target Raised by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $2.00 -> $54.00 | Low | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 4/23/2024 |
KURA Kura Oncology | $19.65 +3.4% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $32.00 | Low | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 4/22/2024 |
RIOT Riot Platforms | $11.93 -1.5% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | N/A | View details for HC Wainwright rating of Riot Platforms (NASDAQ:RIOT) on 4/22/2024 |
KRYS Krystal Biotech | $156.88 +0.8% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $200.00 | Low | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 4/22/2024 |
CRDL Cardiol Therapeutics | C$2.45 -2.0% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy | | N/A | View details for HC Wainwright rating of Cardiol Therapeutics (TSE:CRDL) on 4/22/2024 |
CLMT Calumet Specialty Products Partners | $15.52 -1.0% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Calumet Specialty Products Partners (NASDAQ:CLMT) on 4/22/2024 |
RVPH Reviva Pharmaceuticals | $2.99 +0.3% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 4/22/2024 |
LYTS LSI Industries | $14.77 -2.7% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of LSI Industries (NASDAQ:LYTS) on 4/22/2024 |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
PHGE BiomX | $0.35 +2.9% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 | N/A | View details for HC Wainwright rating of BiomX (NYSEMKT:PHGE) on 4/22/2024 |
ROIV Roivant Sciences | $11.03 +1.4% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 4/22/2024 |
PSTX Poseida Therapeutics | $2.13 +3.9% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Poseida Therapeutics (NASDAQ:PSTX) on 4/22/2024 |
CRDL Cardiol Therapeutics | $1.79 -2.7% | 4/22/2024 | Initiated by | HC Wainwright | Analyst V. Bernardino | Buy | $9.00 | Low | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 4/22/2024 |
BRNS Barinthus Biotherapeutics | $2.50 +2.9% | 4/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 4/19/2024 |
AG First Majestic Silver | $7.03 +1.3% | 4/19/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $7.00 -> $8.50 | Low | View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 4/19/2024 |
ALKS Alkermes | $24.68 +1.0% | 4/19/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $35.00 | Low | View details for HC Wainwright rating of Alkermes (NASDAQ:ALKS) on 4/19/2024 |
OCUL Ocular Therapeutix | $4.75 +12.8% | 4/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 | Low | View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 4/19/2024 |
TGTX TG Therapeutics | $13.47 -3.2% | 4/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $45.00 | Low | View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 4/18/2024 |
URGN UroGen Pharma | $14.15 +2.4% | 4/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $54.00 | Low | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 4/18/2024 |
BEEM Beam Global | $6.54 +1.7% | 4/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Beam Global (NASDAQ:BEEM) on 4/18/2024 |
IGMS IGM Biosciences | $9.40 +22.9% | 4/18/2024 | Reiterated by | HC Wainwright | Analyst R. Burns | Neutral -> Neutral | $12.00 | Low | View details for HC Wainwright rating of IGM Biosciences (NASDAQ:IGMS) on 4/18/2024 |
ASM Avino Silver & Gold Mines | $0.77 +2.6% | 4/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.50 -> $1.60 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 4/18/2024 |
ASM Avino Silver & Gold Mines | $0.77 +2.6% | 4/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.50 -> $1.60 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 4/18/2024 |
ARGX argenx | $372.80 +1.1% | 4/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $451.00 | Low | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 4/18/2024 |
AEYE AudioEye | $14.29 -3.8% | 4/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.00 -> $17.00 | Low | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 4/18/2024 |
ASND Ascendant Resources | C$0.06
| 4/17/2024 | Target Raised by | HC Wainwright | - | | C$0.30 -> C$0.35 | N/A | View details for HC Wainwright rating of Ascendant Resources (TSE:ASND) on 4/17/2024 |
BNTX BioNTech | $87.21 +0.6% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $107.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 4/17/2024 |
ASPI ASP Isotopes | $3.44 +1.8% | 4/17/2024 | Target Raised by | HC Wainwright | Analyst H. Ihle | Buy -> Buy | $5.25 -> $5.50 | Low | View details for HC Wainwright rating of ASP Isotopes (NASDAQ:ASPI) on 4/17/2024 |
CNTB Connect Biopharma | $1.32 -2.9% | 4/17/2024 | Target Raised by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $7.00 -> $8.00 | Low | View details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 4/17/2024 |
CLNN Clene | $0.34 -2.9% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 4/17/2024 |
AEON AEON Biopharma | $5.07 +19.3% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of AEON Biopharma (NASDAQ:AEON) on 4/17/2024 |
CLDX Celldex Therapeutics | $36.30 +0.1% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $80.00 | N/A | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 4/17/2024 |
HALO Halozyme Therapeutics | $38.57 +0.3% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | N/A | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 4/17/2024 |
SAGE Sage Therapeutics | $13.69 +0.8% | 4/17/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $28.00 | N/A | View details for HC Wainwright rating of Sage Therapeutics (NASDAQ:SAGE) on 4/17/2024 |
DTIL Precision BioSciences | $9.38 -3.5% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $60.00 | N/A | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 4/17/2024 |
BLRX BioLineRx | $0.61 +7.0% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | N/A | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 4/17/2024 |
SABS SAB Biotherapeutics | $4.20 +4.7% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/16/2024 |
CMPX Compass Therapeutics | $1.45 -2.0% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Compass Therapeutics (NASDAQ:CMPX) on 4/16/2024 |
CGEM Cullinan Oncology | $25.30 +31.4% | 4/16/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $34.00 -> $29.00 | Low | View details for HC Wainwright rating of Cullinan Oncology (NASDAQ:CGEM) on 4/16/2024 |
LEGN Legend Biotech | $45.30 +2.0% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 4/16/2024 |
MRNS Marinus Pharmaceuticals | $1.41 -0.7% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 4/16/2024 |
ATOS Atossa Therapeutics | $1.53 +0.7% | 4/16/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 4/16/2024 |
ICCM IceCure Medical | $1.20 +0.8% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 4/16/2024 |
TRNS Transcat | $109.83 0.0% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $124.00 | Low | View details for HC Wainwright rating of Transcat (NASDAQ:TRNS) on 4/16/2024 |
MITK Mitek Systems | $12.70 +2.3% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 | Low | View details for HC Wainwright rating of Mitek Systems (NASDAQ:MITK) on 4/16/2024 |
LBPH Longboard Pharmaceuticals | $19.72 +2.4% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $60.00 | Low | View details for HC Wainwright rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 4/16/2024 |
VIRX Viracta Therapeutics | $0.83 -2.3% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Viracta Therapeutics (NASDAQ:VIRX) on 4/16/2024 |
TRX TRX Gold | $0.46 +2.2% | 4/16/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.30 -> $1.40 | Low | View details for HC Wainwright rating of TRX Gold (NYSE:TRX) on 4/16/2024 |
UBX Unity Biotechnology | $1.50 +1.4% | 4/16/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $8.00 | Low | View details for HC Wainwright rating of Unity Biotechnology (NASDAQ:UBX) on 4/16/2024 |
MBOT Microbot Medical | $0.88 +2.3% | 4/16/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $8.00 -> $7.00 | Low | View details for HC Wainwright rating of Microbot Medical (NASDAQ:MBOT) on 4/16/2024 |
LFWD ReWalk Robotics | $4.75 +0.6% | 4/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of ReWalk Robotics (NASDAQ:LFWD) on 4/15/2024 |
INDP Indaptus Therapeutics | $2.11 -3.2% | 4/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Indaptus Therapeutics (NASDAQ:INDP) on 4/15/2024 |
ONCT Oncternal Therapeutics | $8.29 +0.5% | 4/15/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $30.00 -> $28.00 | Low | View details for HC Wainwright rating of Oncternal Therapeutics (NASDAQ:ONCT) on 4/15/2024 |
APLS Apellis Pharmaceuticals | $49.86 +4.0% | 4/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $92.00 | Low | View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 4/15/2024 |
CLSK CleanSpark | $19.23 -1.6% | 4/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 4/15/2024 |
ADCT ADC Therapeutics | $4.34 -2.3% | 4/15/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 4/15/2024 |
ENLV Enlivex Therapeutics | $1.44 -0.7% | 4/12/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $12.00 -> $7.00 | Low | View details for HC Wainwright rating of Enlivex Therapeutics (NASDAQ:ENLV) on 4/12/2024 |
ARVN Arvinas | $32.37 +2.4% | 4/12/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $90.00 -> $87.00 | Low | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 4/12/2024 |
ALPN Alpine Immune Sciences | $64.56 -0.1% | 4/11/2024 | Downgraded by | HC Wainwright | Analyst J. Pantginis | Buy -> Neutral | | Low | View details for HC Wainwright rating of Alpine Immune Sciences (NASDAQ:ALPN) on 4/11/2024 |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
MLTX MoonLake Immunotherapeutics | $42.49 +0.6% | 4/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $100.00 | Low | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 4/11/2024 |
IPHA Innate Pharma | $2.46 +2.5% | 4/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.50 | Low | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 4/11/2024 |
VRTX Vertex Pharmaceuticals | $397.48 -0.1% | 4/11/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $457.00 -> $462.00 | Low | View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/11/2024 |
INAB IN8bio | $1.04
| 4/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 4/10/2024 |
ALXO ALX Oncology | $16.86 -0.1% | 4/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of ALX Oncology (NASDAQ:ALXO) on 4/10/2024 |
PYXS Pyxis Oncology | $4.30
| 4/10/2024 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 4/10/2024 |
FHTX Foghorn Therapeutics | $5.49 +5.0% | 4/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 4/10/2024 |
RAPT RAPT Therapeutics | $8.10 +3.8% | 4/10/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Neutral | | Low | View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 4/10/2024 |
GALT Galectin Therapeutics | $3.45 -1.4% | 4/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Galectin Therapeutics (NASDAQ:GALT) on 4/9/2024 |
ELEV Elevation Oncology | $3.62 -0.5% | 4/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 4/9/2024 |
CDTX Cidara Therapeutics | $12.63 -2.8% | 4/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $120.00 | Low | View details for HC Wainwright rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/8/2024 |
VERV Verve Therapeutics | $6.16 -1.0% | 4/8/2024 | Initiated by | HC Wainwright | Analyst M. Kapoor | Buy | $15.00 | Low | View details for HC Wainwright rating of Verve Therapeutics (NASDAQ:VERV) on 4/8/2024 |
AMLX Amylyx Pharmaceuticals | $1.76 -1.1% | 4/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 4/8/2024 |
TARA Protara Therapeutics | $2.93 -3.9% | 4/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $23.00 | Low | View details for HC Wainwright rating of Protara Therapeutics (NASDAQ:TARA) on 4/8/2024 |
GNFT Genfit | $3.49 +1.2% | 4/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Genfit (NASDAQ:GNFT) on 4/5/2024 |
CLGN CollPlant Biotechnologies | $5.89 +9.9% | 4/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 4/5/2024 |
AQST Aquestive Therapeutics | $4.07 +3.6% | 4/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 4/5/2024 |
GMAB Genmab A/S | $28.15 +2.5% | 4/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 4/4/2024 |
AMPX Amprius Technologies | $1.74 +8.1% | 4/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Amprius Technologies (NYSE:AMPX) on 4/4/2024 |
MIGI Mawson Infrastructure Group | $1.38 -0.7% | 4/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Mawson Infrastructure Group (NASDAQ:MIGI) on 4/4/2024 |
ASXC Asensus Surgical | $0.25 +4.2% | 4/4/2024 | Downgraded by | HC Wainwright | Analyst S. Ramakanth | Buy -> Neutral | $2.00 -> $0.35 | N/A | View details for HC Wainwright rating of Asensus Surgical (NYSEAMERICAN:ASXC) on 4/4/2024 |
CGON CG Oncology | $41.00 +13.3% | 4/4/2024 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $75.00 | Low | View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 4/4/2024 |
MAG MAG Silver | $12.97
| 4/4/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $19.50 -> $16.00 | N/A | View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 4/4/2024 |
FENC Fennec Pharmaceuticals | $9.21 +0.5% | 4/4/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $17.00 -> $18.00 | Low | View details for HC Wainwright rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 4/4/2024 |
COCP Cocrystal Pharma | $1.56 +2.6% | 4/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Cocrystal Pharma (NASDAQ:COCP) on 4/4/2024 |
ICCM IceCure Medical | $1.20 +0.8% | 4/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 4/4/2024 |
URGN UroGen Pharma | $14.15 +2.4% | 4/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $54.00 | Low | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 4/4/2024 |
SBEV Splash Beverage Group | $0.32 -3.1% | 4/4/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $2.50 -> $1.00 | N/A | View details for HC Wainwright rating of Splash Beverage Group (NYSEAMERICAN:SBEV) on 4/4/2024 |
PHGE BiomX | $0.35 +2.9% | 4/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 | N/A | View details for HC Wainwright rating of BiomX (NYSEAMERICAN:PHGE) on 4/3/2024 |
MVST Microvast | $0.41 +5.1% | 4/3/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $8.00 -> $3.00 | Low | View details for HC Wainwright rating of Microvast (NASDAQ:MVST) on 4/3/2024 |
TOMZ TOMI Environmental Solutions | $0.61
| 4/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.50 | Low | View details for HC Wainwright rating of TOMI Environmental Solutions (NASDAQ:TOMZ) on 4/3/2024 |
FPAY FlexShopper | $1.05 +1.0% | 4/3/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $2.00 -> $2.50 | Low | View details for HC Wainwright rating of FlexShopper (NASDAQ:FPAY) on 4/3/2024 |
OPK OPKO Health | $1.26 +3.3% | 4/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 4/3/2024 |
EVAX Evaxion Biotech A/S | $4.18 +1.5% | 4/3/2024 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of Evaxion Biotech A/S (NASDAQ:EVAX) on 4/3/2024 |
OCGN Ocugen | $1.28 +8.5% | 4/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Ocugen (NASDAQ:OCGN) on 4/3/2024 |
ATAI Atai Life Sciences | $1.93 +4.9% | 4/3/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $20.00 -> $15.00 | N/A | View details for HC Wainwright rating of Atai Life Sciences (NASDAQ:ATAI) on 4/3/2024 |
ZVRA Zevra Therapeutics | $4.52
| 4/3/2024 | Reiterated by | HC Wainwright | Analyst O. Livnat | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Zevra Therapeutics (NASDAQ:ZVRA) on 4/3/2024 |
ROIV Roivant Sciences | $11.03 +1.4% | 4/3/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $17.00 -> $18.00 | Low | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 4/3/2024 |
BKSY BlackSky Technology | $1.26
| 4/3/2024 | Initiated by | HC Wainwright | Analyst S. Buck | Buy | $2.50 | Low | View details for HC Wainwright rating of BlackSky Technology (NYSE:BKSY) on 4/3/2024 |
MIRM Mirum Pharmaceuticals | $24.46 -0.1% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $58.00 | Low | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 4/2/2024 |
LLAP Terran Orbital | $1.34 -2.9% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of Terran Orbital (NYSE:LLAP) on 4/2/2024 |
KALA KALA BIO | $6.46 +4.5% | 4/2/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $22.00 -> $21.00 | Low | View details for HC Wainwright rating of KALA BIO (NASDAQ:KALA) on 4/2/2024 |
IREN Iris Energy | $5.08 -1.7% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Iris Energy (NASDAQ:IREN) on 4/2/2024 |
PPSI Pioneer Power Solutions | $3.90 -0.5% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Pioneer Power Solutions (NASDAQ:PPSI) on 4/2/2024 |
ATOS Atossa Therapeutics | $1.53 +0.7% | 4/2/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 4/2/2024 |
GNLX Genelux | $3.40 +2.4% | 4/2/2024 | Target Lowered by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $35.00 -> $32.00 | Low | View details for HC Wainwright rating of Genelux (NASDAQ:GNLX) on 4/2/2024 |
SABS SAB Biotherapeutics | $4.20 +4.7% | 4/2/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $6.00 | Low | View details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/2/2024 |
ACET Adicet Bio | $1.68 -7.2% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 4/2/2024 |
ALDX Aldeyra Therapeutics | $3.93 -0.3% | 4/2/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 4/2/2024 |
CARM Carisma Therapeutics | $1.64
| 4/2/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $11.00 -> $9.00 | Low | View details for HC Wainwright rating of Carisma Therapeutics (NASDAQ:CARM) on 4/2/2024 |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
AXSM Axsome Therapeutics | $71.71 +0.3% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $190.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 4/2/2024 |
ENTX Entera Bio | $1.98 -1.0% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Entera Bio (NASDAQ:ENTX) on 4/2/2024 |
EQ Equillium | $1.71 -5.5% | 4/2/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $4.00 -> $5.00 | Low | View details for HC Wainwright rating of Equillium (NASDAQ:EQ) on 4/2/2024 |
ANVS Annovis Bio | $18.08 +32.9% | 4/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Annovis Bio (NYSE:ANVS) on 4/2/2024 |
GALT Galectin Therapeutics | $3.45 -1.4% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Galectin Therapeutics (NASDAQ:GALT) on 4/1/2024 |
ALT Altimmune | $7.26 +0.8% | 4/1/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $15.00 -> $12.00 | Low | View details for HC Wainwright rating of Altimmune (NASDAQ:ALT) on 4/1/2024 |
BMEA Biomea Fusion | $10.78 +3.0% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 4/1/2024 |
ATNM Actinium Pharmaceuticals | $6.87 +4.7% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | N/A | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 4/1/2024 |
IRON Disc Medicine | $27.55 +3.9% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $70.00 | Low | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 4/1/2024 |
DPRO Draganfly | $0.26 -3.7% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $1.00 | Low | View details for HC Wainwright rating of Draganfly (NASDAQ:DPRO) on 4/1/2024 |
DARE Daré Bioscience | $0.31 +7.0% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Daré Bioscience (NASDAQ:DARE) on 4/1/2024 |
SOL Emeren Group | $1.89 +4.4% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Emeren Group (NYSE:SOL) on 4/1/2024 |
LEGN Legend Biotech | $45.30 +2.0% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 4/1/2024 |
ATLX Atlas Lithium | $14.67 +4.4% | 4/1/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $52.00 -> $40.00 | Low | View details for HC Wainwright rating of Atlas Lithium (NASDAQ:ATLX) on 4/1/2024 |
UNCY Unicycive Therapeutics | $1.03 +6.2% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.50 | Low | View details for HC Wainwright rating of Unicycive Therapeutics (NASDAQ:UNCY) on 4/1/2024 |
APLM Apollomics | $0.45 -4.3% | 4/1/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $17.00 -> $5.00 | Low | View details for HC Wainwright rating of Apollomics (NASDAQ:APLM) on 4/1/2024 |
ASMB Assembly Biosciences | $12.65 -5.3% | 4/1/2024 | Reiterated by | HC Wainwright | - | Neutral | | Low | View details for HC Wainwright rating of Assembly Biosciences (NASDAQ:ASMB) on 4/1/2024 |
IVA Inventiva | $3.25 +2.8% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $22.00 | Low | View details for HC Wainwright rating of Inventiva (NASDAQ:IVA) on 4/1/2024 |
ITRM Iterum Therapeutics | $1.69 +7.6% | 4/1/2024 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Iterum Therapeutics (NASDAQ:ITRM) on 4/1/2024 |
CALC CalciMedica | $5.45 +3.0% | 4/1/2024 | Reiterated by | HC Wainwright | Analyst J. Pantginis | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of CalciMedica (NASDAQ:CALC) on 4/1/2024 |
AFMD Affimed | $5.03 +3.1% | 4/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Affimed (NASDAQ:AFMD) on 4/1/2024 |
FEMY Femasys | $1.27 -4.5% | 4/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.00 -> $12.00 | Low | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 4/1/2024 |
SLRN Acelyrin | $4.24
| 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 | Low | View details for HC Wainwright rating of Acelyrin (NASDAQ:SLRN) on 4/1/2024 |
EDAP Edap Tms | $7.28 -1.6% | 4/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $16.00 -> $19.00 | Low | View details for HC Wainwright rating of Edap Tms (NASDAQ:EDAP) on 4/1/2024 |
LABP Landos Biopharma | $22.21 -1.2% | 4/1/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Neutral | $50.00 -> $20.42 | Low | View details for HC Wainwright rating of Landos Biopharma (NASDAQ:LABP) on 4/1/2024 |
GANX Gain Therapeutics | $3.03 -1.3% | 4/1/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 4/1/2024 |
SYRS Syros Pharmaceuticals | $5.04 -1.2% | 4/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Syros Pharmaceuticals (NASDAQ:SYRS) on 4/1/2024 |
IMNN Imunon | $1.44
| 4/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $12.00 -> $13.00 | Low | View details for HC Wainwright rating of Imunon (NASDAQ:IMNN) on 4/1/2024 |
USIO Usio | $1.46 -2.0% | 4/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $3.50 -> $4.00 | Low | View details for HC Wainwright rating of Usio (NASDAQ:USIO) on 4/1/2024 |
ACRV Acrivon Therapeutics | $8.46 -0.1% | 3/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | N/A | View details for HC Wainwright rating of Acrivon Therapeutics (NASDAQ:ACRV) on 3/28/2024 |
HUT Hut 8 | $8.81 -0.6% | 3/28/2024 | Target Raised by | HC Wainwright | Analyst M. Colonnese | Sell -> Sell | $7.00 -> $9.00 | N/A | View details for HC Wainwright rating of Hut 8 (NASDAQ:HUT) on 3/28/2024 |
AKBA Akebia Therapeutics | $1.34 +0.8% | 3/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $6.00 | N/A | View details for HC Wainwright rating of Akebia Therapeutics (NASDAQ:AKBA) on 3/28/2024 |
DTIL Precision BioSciences | $9.38 -3.5% | 3/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $60.00 | N/A | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 3/28/2024 |
DRRX DURECT | $0.93 +2.2% | 3/28/2024 | Reiterated by | HC Wainwright | Analyst E. Arce | Neutral | | Low | View details for HC Wainwright rating of DURECT (NASDAQ:DRRX) on 3/28/2024 |
CELC Celcuity | $15.92 +1.0% | 3/28/2024 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Celcuity (NASDAQ:CELC) on 3/28/2024 |
ERAS Erasca | $1.89 +0.5% | 3/28/2024 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 3/28/2024 |
NUVB Nuvation Bio | $2.68 +2.3% | 3/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $8.00 | Low | View details for HC Wainwright rating of Nuvation Bio (NYSE:NUVB) on 3/28/2024 |
KRRO Korro Bio | $62.93 +7.5% | 3/28/2024 | Target Raised by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $100.00 -> $115.00 | Low | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 3/28/2024 |
REE REE Automotive | $4.10 -5.1% | 3/28/2024 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of REE Automotive (NASDAQ:REE) on 3/28/2024 |
AQMS Aqua Metals | $0.50 -2.0% | 3/28/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Aqua Metals (NASDAQ:AQMS) on 3/28/2024 |
PPTA Perpetua Resources | $5.78 +1.0% | 3/28/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.50 | Low | View details for HC Wainwright rating of Perpetua Resources (NASDAQ:PPTA) on 3/28/2024 |
GLYC GlycoMimetics | $1.64 -4.1% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of GlycoMimetics (NASDAQ:GLYC) on 3/27/2024 |
NVCR NovoCure | $12.64 +3.3% | 3/27/2024 | Target Raised by | HC Wainwright | - | Neutral -> Neutral | $22.00 -> $24.00 | Low | View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 3/27/2024 |
ATAI Atai Life Sciences | $1.93 +4.9% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | N/A | View details for HC Wainwright rating of Atai Life Sciences (NASDAQ:ATAI) on 3/27/2024 |
ETNB 89bio | $8.26 +0.1% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $31.00 | Low | View details for HC Wainwright rating of 89bio (NASDAQ:ETNB) on 3/27/2024 |
CLSK CleanSpark | $19.23 -1.6% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 3/27/2024 |
PDSB PDS Biotechnology | $3.27 +0.3% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | Low | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 3/27/2024 |
ARGX argenx | $372.80 +1.1% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $451.00 | Low | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 3/27/2024 |
ABOS Acumen Pharmaceuticals | $3.17 -0.6% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Acumen Pharmaceuticals (NASDAQ:ABOS) on 3/27/2024 |
VIGL Vigil Neuroscience | $2.71 +5.0% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $24.00 | Low | View details for HC Wainwright rating of Vigil Neuroscience (NASDAQ:VIGL) on 3/27/2024 |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
ANNX Annexon | $4.70 +2.4% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Annexon (NASDAQ:ANNX) on 3/27/2024 |
WPRT Westport Fuel Systems | $5.69 +0.9% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Westport Fuel Systems (NASDAQ:WPRT) on 3/27/2024 |
EMX EMX Royalty | $1.92 +1.1% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.50 | N/A | View details for HC Wainwright rating of EMX Royalty (NYSEAMERICAN:EMX) on 3/27/2024 |
FCUUF Fission Uranium | $0.81 +5.2% | 3/27/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.70 -> $1.90 | Low | View details for HC Wainwright rating of Fission Uranium (OTCMKTS:FCUUF) on 3/27/2024 |
SNDX Syndax Pharmaceuticals | $21.06 +2.4% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $41.00 | Low | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 3/27/2024 |
APTO Aptose Biosciences | $1.22 +5.2% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $23.00 | Low | View details for HC Wainwright rating of Aptose Biosciences (NASDAQ:APTO) on 3/27/2024 |
DCTH Delcath Systems | $5.30 +0.8% | 3/27/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $18.00 -> $20.00 | Low | View details for HC Wainwright rating of Delcath Systems (NASDAQ:DCTH) on 3/27/2024 |
BCAB BioAtla | $2.54 +12.9% | 3/27/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $7.00 | Low | View details for HC Wainwright rating of BioAtla (NASDAQ:BCAB) on 3/27/2024 |
KPRX Kiora Pharmaceuticals | $0.47 -2.1% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | Low | View details for HC Wainwright rating of Kiora Pharmaceuticals (NASDAQ:KPRX) on 3/27/2024 |
GMAB Genmab A/S | $28.15 +2.5% | 3/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 3/27/2024 |
BLRX BioLineRx | $0.61 +7.0% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | Low | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 3/26/2024 |
ATNM Actinium Pharmaceuticals | $6.87 +4.7% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | N/A | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 3/26/2024 |
PRAX Praxis Precision Medicines | $54.80 +3.6% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $105.00 | Low | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 3/26/2024 |
VKTX Viking Therapeutics | $74.31 +7.9% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 | Low | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024 |
BTDR Bitdeer Technologies Group | $6.35 -1.7% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 3/26/2024 |
APRE Aprea Therapeutics | $5.20 -2.8% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Aprea Therapeutics (NASDAQ:APRE) on 3/26/2024 |
BITF Bitfarms | $1.96 -2.0% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Bitfarms (NASDAQ:BITF) on 3/26/2024 |
MRNS Marinus Pharmaceuticals | $1.41 -0.7% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 3/26/2024 |
STRO Sutro Biopharma | $3.42
| 3/26/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $16.00 -> $12.00 | Low | View details for HC Wainwright rating of Sutro Biopharma (NASDAQ:STRO) on 3/26/2024 |
STOK Stoke Therapeutics | $12.41 +6.2% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 | Low | View details for HC Wainwright rating of Stoke Therapeutics (NASDAQ:STOK) on 3/26/2024 |
AXSM Axsome Therapeutics | $71.71 +0.3% | 3/26/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $180.00 -> $190.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 3/26/2024 |
BTM Bitcoin Depot | $1.80
| 3/26/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $5.00 -> $4.00 | Low | View details for HC Wainwright rating of Bitcoin Depot (NASDAQ:BTM) on 3/26/2024 |
ADMA ADMA Biologics | $6.55 +1.7% | 3/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $7.50 | Low | View details for HC Wainwright rating of ADMA Biologics (NASDAQ:ADMA) on 3/26/2024 |
ATXS Astria Therapeutics | $9.00 -1.9% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 3/25/2024 |
ESPR Esperion Therapeutics | $1.90 -4.5% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 | Low | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 3/25/2024 |
IVVD Invivyd | $2.15 +3.9% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Invivyd (NASDAQ:IVVD) on 3/25/2024 |
OTLK Outlook Therapeutics | $8.43 +2.9% | 3/25/2024 | Target Raised by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Outlook Therapeutics (NASDAQ:OTLK) on 3/25/2024 |
RANI Rani Therapeutics | $6.68 +1.8% | 3/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $16.00 -> $12.00 | Low | View details for HC Wainwright rating of Rani Therapeutics (NASDAQ:RANI) on 3/25/2024 |
TIL Instil Bio | $10.60 +1.9% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | N/A | View details for HC Wainwright rating of Instil Bio (NASDAQ:TIL) on 3/25/2024 |
BTCS BTCS | $1.53 +6.3% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of BTCS (NASDAQ:BTCS) on 3/25/2024 |
LGO Largo | $1.60 +6.7% | 3/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $9.00 -> $4.60 | Low | View details for HC Wainwright rating of Largo (NYSE:LGO) on 3/25/2024 |
RGLS Regulus Therapeutics | $2.42 +6.6% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Regulus Therapeutics (NASDAQ:RGLS) on 3/25/2024 |
HOOK Hookipa Pharma | $0.89 +11.2% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.50 | Low | View details for HC Wainwright rating of Hookipa Pharma (NASDAQ:HOOK) on 3/25/2024 |
RMTI Rockwell Medical | $1.46 -3.3% | 3/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $11.00 -> $9.00 | Low | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 3/25/2024 |
RVPH Reviva Pharmaceuticals | $2.99 +0.3% | 3/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 3/25/2024 |
ABSI Absci | $4.58 +2.7% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 3/22/2024 |
XFOR X4 Pharmaceuticals | $1.17 +3.6% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 3/22/2024 |
MIST Milestone Pharmaceuticals | $1.55 -2.5% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 3/22/2024 |
CKPT Checkpoint Therapeutics | $1.43 +0.7% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $34.00 | Low | View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 3/22/2024 |
NXTC NextCure | $1.35 +4.7% | 3/22/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $8.00 | Low | View details for HC Wainwright rating of NextCure (NASDAQ:NXTC) on 3/22/2024 |
CBUS Cibus | $15.84 +1.9% | 3/22/2024 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Cibus (NASDAQ:CBUS) on 3/22/2024 |
ASM Avino Silver & Gold Mines | $0.77 +2.6% | 3/22/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.80 -> $1.50 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 3/22/2024 |
ASM Avino Silver & Gold Mines | $0.77 +2.6% | 3/22/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.80 -> $1.50 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 3/22/2024 |
CABA Cabaletta Bio | $11.01 -9.6% | 3/22/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $25.00 -> $30.00 | Low | View details for HC Wainwright rating of Cabaletta Bio (NASDAQ:CABA) on 3/22/2024 |
IRON Disc Medicine | $27.55 +3.9% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $70.00 | Low | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 3/22/2024 |
ARMP Armata Pharmaceuticals | $2.76 +9.1% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | N/A | View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 3/22/2024 |
BOLT Bolt Biotherapeutics | $1.11 -4.3% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 3/22/2024 |
ASXC Asensus Surgical | $0.25 +4.2% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 | N/A | View details for HC Wainwright rating of Asensus Surgical (NYSEAMERICAN:ASXC) on 3/22/2024 |
OKYO OKYO Pharma | $1.47 +1.4% | 3/22/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $6.00 -> $7.00 | Low | View details for HC Wainwright rating of OKYO Pharma (NASDAQ:OKYO) on 3/22/2024 |
BLTE Belite Bio | $39.75 +4.6% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 | Low | View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 3/22/2024 |
IDN Intellicheck | $3.19 +0.3% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of Intellicheck (NYSE:IDN) on 3/22/2024 |
IFRX InflaRx | $1.33 -4.3% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 3/22/2024 |
PYXS Pyxis Oncology | $4.30
| 3/22/2024 | Target Raised by | HC Wainwright | Analyst S. Ramakanth | Buy -> Buy | $4.00 -> $7.00 | Low | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 3/22/2024 |
MDWD MediWound | $18.24 +3.3% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 | Low | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 3/22/2024 |
IPHA Innate Pharma | $2.46 +2.5% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.50 | Low | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 3/22/2024 |
ELDN Eledon Pharmaceuticals | $2.06 +2.0% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | Low | View details for HC Wainwright rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 3/22/2024 |
LYRA Lyra Therapeutics | $4.72 -8.7% | 3/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Lyra Therapeutics (NASDAQ:LYRA) on 3/22/2024 |
NKTX Nkarta | $6.87 +0.7% | 3/22/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $22.00 -> $20.00 | Low | View details for HC Wainwright rating of Nkarta (NASDAQ:NKTX) on 3/22/2024 |
BRNS Barinthus Biotherapeutics | $2.50 +2.9% | 3/21/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $15.00 -> $8.00 | Low | View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 3/21/2024 |
INKT MiNK Therapeutics | $0.93 +6.9% | 3/21/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $9.00 | Low | View details for HC Wainwright rating of MiNK Therapeutics (NASDAQ:INKT) on 3/21/2024 |